LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint [Yahoo! Finance]
LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences
Goldman Sachs Says Improving Growth Could Propel These 2 Stocks Higher [Yahoo! Finance]
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $75.00 price target on the stock.